3 Drugs On Horizon Could Help Lower Lp(a), A Genetic Form Of Cholesterol That Raises Heart Attack Risk

3 Drugs On Horizon Could Help Lower Lp(a), A Genetic Form Of Cholesterol That Raises Heart Attack Risk At least three pharma firms — Novartis, Amgen, and Eli Lilly — say they're closer to unraveling the mystery of lipoprotein(a), which is a more dangerous cousin to LDL cholesterol. Diet and exercise don't influence lp(a) levels, CNBC reported, and there is currently no medication for it. https://kffhealthnews.org/morning-breakout/lauren-will-do-this-one-pharma/